SK287430B6 - Stabilná soľ derivátov 3,3-difenylpropylamínov, spôsob jej výroby a stabilné medziprodukty na jej výrobu - Google Patents

Stabilná soľ derivátov 3,3-difenylpropylamínov, spôsob jej výroby a stabilné medziprodukty na jej výrobu Download PDF

Info

Publication number
SK287430B6
SK287430B6 SK657-2002A SK6572002A SK287430B6 SK 287430 B6 SK287430 B6 SK 287430B6 SK 6572002 A SK6572002 A SK 6572002A SK 287430 B6 SK287430 B6 SK 287430B6
Authority
SK
Slovakia
Prior art keywords
acid
diisopropylamino
phenylpropyl
phenyl
ester
Prior art date
Application number
SK657-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK6572002A3 (en
Inventor
Claus Meese
Original Assignee
Schwarz Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287430(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schwarz Pharma Ag filed Critical Schwarz Pharma Ag
Publication of SK6572002A3 publication Critical patent/SK6572002A3/sk
Publication of SK287430B6 publication Critical patent/SK287430B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Detergent Compositions (AREA)
SK657-2002A 1999-11-16 2000-11-15 Stabilná soľ derivátov 3,3-difenylpropylamínov, spôsob jej výroby a stabilné medziprodukty na jej výrobu SK287430B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19955190A DE19955190A1 (de) 1999-11-16 1999-11-16 Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
PCT/EP2000/011309 WO2001035957A1 (de) 1999-11-16 2000-11-15 Stabile salze neuartiger derivate von 3,3-diphenylpropylaminen

Publications (2)

Publication Number Publication Date
SK6572002A3 SK6572002A3 (en) 2002-12-03
SK287430B6 true SK287430B6 (sk) 2010-09-07

Family

ID=7929277

Family Applications (3)

Application Number Title Priority Date Filing Date
SK657-2002A SK287430B6 (sk) 1999-11-16 2000-11-15 Stabilná soľ derivátov 3,3-difenylpropylamínov, spôsob jej výroby a stabilné medziprodukty na jej výrobu
SK5024-2013A SK288384B6 (sk) 1999-11-16 2000-11-15 Deriváty 3,3-difenylpropylamínov a spôsob ich výroby
SK5027-2010A SK288185B6 (sk) 1999-11-16 2000-11-15 Stabilné soli derivátov 3,3-difenylpropylamínov

Family Applications After (2)

Application Number Title Priority Date Filing Date
SK5024-2013A SK288384B6 (sk) 1999-11-16 2000-11-15 Deriváty 3,3-difenylpropylamínov a spôsob ich výroby
SK5027-2010A SK288185B6 (sk) 1999-11-16 2000-11-15 Stabilné soli derivátov 3,3-difenylpropylamínov

Country Status (30)

Country Link
US (1) US6858650B1 (ja)
EP (3) EP1690536B1 (ja)
JP (6) JP4083431B2 (ja)
KR (2) KR100536095B1 (ja)
CN (1) CN1215045C (ja)
AT (3) ATE337293T1 (ja)
AU (1) AU778132B2 (ja)
BR (1) BRPI0015610C1 (ja)
CA (1) CA2389749C (ja)
CY (2) CY1106204T1 (ja)
CZ (2) CZ302967B6 (ja)
DE (5) DE29923134U1 (ja)
DK (3) DK1481964T3 (ja)
EA (1) EA005588B1 (ja)
ES (3) ES2270240T3 (ja)
GE (1) GEP20084430B (ja)
HK (3) HK1045148B (ja)
HU (2) HU227608B1 (ja)
IL (2) IL149567A0 (ja)
IS (2) IS2124B (ja)
MX (1) MXPA02004603A (ja)
NO (2) NO323920B1 (ja)
NZ (1) NZ519230A (ja)
PL (1) PL201422B1 (ja)
PT (3) PT1481964E (ja)
SI (3) SI1481964T1 (ja)
SK (3) SK287430B6 (ja)
UA (2) UA73324C2 (ja)
WO (1) WO2001035957A1 (ja)
ZA (1) ZA200203315B (ja)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10315878B4 (de) 2003-04-08 2009-06-04 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
US8034823B2 (en) 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
US8067594B2 (en) * 2006-05-24 2011-11-29 Pfizer Inc. Process for the production of benzopyran-2-ol derivatives
EP1862449A1 (en) * 2006-05-31 2007-12-05 Schwarz Pharma Ltd. A shortened synthesis of substituted hydroxymethyl phenols
BRPI0711881B1 (pt) * 2006-05-31 2016-09-27 Schwarz Pharma Ltd síntese de hidroximetil fenóis substituídos
IES20060424A2 (en) * 2006-06-08 2007-10-31 Schwarz Pharma Ltd Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
PE20120476A1 (es) 2006-06-09 2012-04-20 Sanol Arznei Schwarz Gmbh Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
US7807715B2 (en) 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
DE602007008389D1 (de) 2006-06-09 2010-09-23 Schwarz Pharma Ltd Synthese von phenolischen estern von hydroxymethylphenolen
MX2008015973A (es) 2006-06-12 2009-01-12 Sanol Arznei Schwarz Gmbh Intermediario quiralico nuevo, proceso para producir el mismo y su uso en la fabricacion de tolterodina, fesoterodina o el metabolito activo de los mismos.
IES20060435A2 (en) 2006-06-12 2007-12-12 Schwarz Pharma Ltd Shortened synthesis using paraformaldehyde or trioxane
WO2009037569A2 (en) * 2007-09-21 2009-03-26 Actavis Group Ptc Ehf An improved process for the preparation of fesoterodine
US20100297241A1 (en) * 2007-10-01 2010-11-25 Actavis Group Ptc Ehf Amorphous Fesoterodine Fumarate
EP2294047A2 (en) * 2008-04-04 2011-03-16 Actavis Group PTC EHF Novel mandelate salt of fesoterodine
US20110171274A1 (en) * 2008-07-21 2011-07-14 Actavis Group Ptc Ehf Fesoterodine Substantially Free of Dehydroxy Impurity
IT1392082B1 (it) * 2008-12-10 2012-02-09 Chemi Spa Nuove forme solide della fesoterodina fumarato
MX2011011937A (es) 2009-05-11 2012-01-27 Ratiopharm Gmbh Desfesoterodina en la forma de una sal del acido tartarico.
IT1394217B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
IT1394219B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina fumarato di elevata purezza.
US20120220655A1 (en) 2009-09-03 2012-08-30 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Crystalline forms of fesoterodine fumarate and fesoterodine base
IT1396373B1 (it) * 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
EP2316432A1 (de) 2009-10-30 2011-05-04 ratiopharm GmbH Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
US20110124903A1 (en) * 2009-11-20 2011-05-26 Actavis Group Ptc Ehf Solid state forms of fesoterodine intermediates
IT1397521B1 (it) * 2009-12-21 2013-01-16 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
IT1397920B1 (it) * 2010-02-08 2013-02-04 Dipharma Francis Srl Forma cristallina di fesoterodina fumarato e procedimento per la sua preparazione
US20130172411A1 (en) 2010-03-22 2013-07-04 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine
US8748433B2 (en) 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists
WO2011141932A2 (en) 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) * 2010-05-17 2011-11-24 Orchid Chemicals And Pharmaceuticals Limited Improved process for diphenylpropylamine derivatives
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
WO2012025941A2 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Processes for the preparation of fesoterodine
IT1403094B1 (it) 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
WO2012098560A2 (en) * 2011-01-17 2012-07-26 Msn Laboratories Limited Process for the preparation of muscarinic receptor antagonist
TWI590821B (zh) 2011-01-18 2017-07-11 輝瑞有限公司 固體分子分散液
EP2508173A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Stabilized pharmaceutical composition comprising fesoterodine
EP2508175A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
CA2873721C (en) 2012-05-04 2021-06-22 Crystal Pharma, S.A.U. Process for the preparation of optically active 3,3-diphenylpropylamines
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
TR201721437A2 (tr) 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
EP4237405A1 (en) * 2020-10-27 2023-09-06 Wella Germany GmbH 2-methoxymethyl-p-phenylenediamine in cosmetic grade quality

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817863B (en) * 1980-11-14 1983-06-29 Lilly Co Eli (-)n-methyl-3-(2-methylphenoxy)-3-phenylpropylamnie,antidepressant
IL66831A0 (en) * 1981-10-05 1982-12-31 Kefalas As Indane derivatives
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
EP0445749B1 (en) * 1990-03-08 1996-07-10 Fujisawa Pharmaceutical Co., Ltd. N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments
JPH0483431A (ja) * 1990-07-26 1992-03-17 Seiko Epson Corp 選択呼出受信機
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen

Also Published As

Publication number Publication date
HK1067114A1 (en) 2005-04-01
SK288384B6 (sk) 2016-08-01
HUP0204034A2 (hu) 2003-03-28
JP5290351B2 (ja) 2013-09-18
SI1690536T1 (sl) 2008-08-31
HU228197B1 (en) 2013-01-28
CY1110389T1 (el) 2015-04-29
JP2011148824A (ja) 2011-08-04
KR100563149B1 (ko) 2006-03-21
NO20065380L (no) 2002-05-15
JP2010180243A (ja) 2010-08-19
CN1215045C (zh) 2005-08-17
MXPA02004603A (es) 2004-09-10
PL356766A1 (en) 2004-07-12
HUP0900587A3 (en) 2010-04-28
WO2001035957A8 (de) 2001-06-21
DE50013365D1 (de) 2006-10-05
DE50015163D1 (de) 2008-06-26
US6858650B1 (en) 2005-02-22
ES2236032T3 (es) 2005-07-16
ATE337293T1 (de) 2006-09-15
JP4083431B2 (ja) 2008-04-30
EP1481964B1 (de) 2006-08-23
DK1230209T3 (da) 2005-05-30
HU227608B1 (en) 2011-09-28
WO2001035957A3 (de) 2001-12-27
UA73324C2 (uk) 2005-07-15
HU0900587D0 (en) 2009-11-30
EA005588B1 (ru) 2005-04-28
HK1095736A1 (en) 2007-05-18
HUP0204034A3 (en) 2004-12-28
SI1481964T1 (sl) 2006-12-31
ATE286872T1 (de) 2005-01-15
SK288185B6 (sk) 2014-04-02
SI1230209T1 (en) 2005-06-30
BR0015610A (pt) 2002-07-30
CZ302497B6 (cs) 2011-06-15
IS8382A (is) 2006-03-29
PL201422B1 (pl) 2009-04-30
EP1230209A2 (de) 2002-08-14
JP5503393B2 (ja) 2014-05-28
NO20022314D0 (no) 2002-05-15
ES2236032T7 (es) 2012-06-14
CA2389749C (en) 2009-03-31
ES2303708T3 (es) 2008-08-16
CZ20021343A3 (cs) 2002-09-11
JP2014111589A (ja) 2014-06-19
EP1690536B1 (de) 2008-05-14
WO2001035957A1 (de) 2001-05-25
CN1390194A (zh) 2003-01-08
KR20050100711A (ko) 2005-10-19
JP2003514018A (ja) 2003-04-15
IS6351A (is) 2002-04-19
HK1045148A1 (en) 2002-11-15
DE19955190A1 (de) 2001-06-21
EP1481964A1 (de) 2004-12-01
NO323920B1 (no) 2007-07-23
BRPI0015610B1 (pt) 2016-04-19
DE50009239D1 (de) 2005-02-17
NO20022314L (no) 2002-05-15
DK1690536T3 (da) 2008-09-01
ZA200203315B (en) 2003-09-23
PT1690536E (pt) 2008-07-14
JP5717824B2 (ja) 2015-05-13
PT1230209E (pt) 2005-05-31
KR100536095B1 (ko) 2005-12-12
BRPI0015610C1 (pt) 2021-05-25
CY1106204T1 (el) 2011-06-08
HK1045148B (zh) 2005-05-06
DK1481964T3 (da) 2006-11-27
IL149567A (en) 2007-08-19
GEP20084430B (ja) 2008-07-25
AU778132B2 (en) 2004-11-18
UA77322C2 (en) 2006-11-15
PT1481964E (pt) 2006-12-29
SK6572002A3 (en) 2002-12-03
JP5650924B2 (ja) 2015-01-07
CZ302967B6 (cs) 2012-01-25
EP1230209B3 (de) 2011-10-05
ATE395056T1 (de) 2008-05-15
NZ519230A (en) 2004-11-26
DE29923134U1 (de) 2000-06-29
JP2010180242A (ja) 2010-08-19
EP1690536A2 (de) 2006-08-16
CA2389749A1 (en) 2001-05-25
EP1690536A3 (de) 2006-08-23
IL149567A0 (en) 2002-11-10
EP1230209B1 (de) 2005-01-12
AU2666701A (en) 2001-05-30
KR20020059744A (ko) 2002-07-13
JP2007137895A (ja) 2007-06-07
ES2270240T3 (es) 2007-04-01
BR0015610B8 (pt) 2017-10-31
IS2124B (is) 2006-07-14
IS2673B (is) 2010-09-15
NO332637B1 (no) 2012-11-26
EA200200511A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
SK287430B6 (sk) Stabilná soľ derivátov 3,3-difenylpropylamínov, spôsob jej výroby a stabilné medziprodukty na jej výrobu
KR100486394B1 (ko) 3,3-디페닐-프로필아민의 신규한 유도체의 안정한 염
WO2012098560A2 (en) Process for the preparation of muscarinic receptor antagonist
JP4005771B2 (ja) アミノエチルフェノキシ酢酸誘導体の結晶多形
JP2000212139A (ja) アミノエチルフェノキシ酢酸誘導体の結晶多形
JP2000212138A (ja) アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形

Legal Events

Date Code Title Description
QB4A Licence contract registered or granted

Free format text: EXCLUSIVE LICENCE

Name of requester: PFIZER INC., NEW YORK, NY, US

Effective date: 20060412

TC4A Change of owner's name

Owner name: UCB PHARMA GMBH, MONHEIM, DE

Effective date: 20180502

MK4A Patent expired

Expiry date: 20201115